{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:28:58Z","timestamp":1758709738055},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[1999,10,1]]},"DOI":"10.1038\/sj.gt.3300999","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T16:50:10Z","timestamp":1032367810000},"page":"1788-1792","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements"],"prefix":"10.1038","volume":"6","author":[{"given":"F A","family":"Ayuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"K\u00fchlcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U M","family":"Schade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-G","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A R","family":"Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Fehse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,10,6]]},"reference":[{"key":"BF3300999_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese RM et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years Science 1995 270: 475\u2013480","journal-title":"Science"},{"key":"BF3300999_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney CM et al. Use of gene-modified virus-specific T lymphocytes to control Epstein\u2013Barr-virus-related lymphoproliferation Lancet 1995 345: 9\u201313","journal-title":"Lancet"},{"key":"BF3300999_CR3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1089\/hum.1996.7.10-1281","volume":"7","author":"RA Morgan","year":"1996","unstructured":"Morgan RA, Walker R . Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins (clinical protocol) Hum Gene Ther 1996 7: 1281\u20131306","journal-title":"Hum Gene Ther"},{"key":"BF3300999_CR4","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","volume":"276","author":"C Bonini","year":"1997","unstructured":"Bonini C et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 1997 276: 1719\u20131724","journal-title":"Science"},{"key":"BF3300999_CR5","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/JVI.72.6.4882-4892.1998","volume":"72","author":"KE Pollok","year":"1998","unstructured":"Pollok KE et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments J Virol 1998 72: 4882\u20134892","journal-title":"J Virol"},{"key":"BF3300999_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1365-2141.1998.00785.x","volume":"102","author":"B Fehse","year":"1998","unstructured":"Fehse B et al. Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin (FN) Br J Haematol 1998 102: 566\u2013574","journal-title":"Br J Haematol"},{"key":"BF3300999_CR7","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.1073\/pnas.92.17.7739","volume":"92","author":"BA Bunnell","year":"1995","unstructured":"Bunnell BA et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes Proc Natl Acad Sci USA 1995 92: 7739\u20137743","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300999_CR8","doi-asserted-by":"publisher","first-page":"11842","DOI":"10.1073\/pnas.93.21.11842","volume":"93","author":"S Sharma","year":"1996","unstructured":"Sharma S, Cantwell M, Kipps TJ, Friedmann T . Efficient infection of a human T-cell line and of primary peripheral blood leukocytes with a pseudotyped retrovirus vector Proc Natl Acad Sci USA 1996 93: 11842\u201311847","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300999_CR9","first-page":"695","volume":"3","author":"T Rudoll","year":"1996","unstructured":"Rudoll T et al. High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes Gene Therapy 1996 3: 695\u2013705","journal-title":"Gene Therapy"},{"key":"BF3300999_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1046\/j.1365-2141.1998.01020.x","volume":"103","author":"M Introna","year":"1998","unstructured":"Introna M et al. Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cells Br J Haematol 1998 103: 449\u2013461","journal-title":"Br J Haematol"},{"key":"BF3300999_CR11","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V89.6.1987","volume":"89","author":"BA Bunnell","year":"1997","unstructured":"Bunnell BA et al. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector Blood 1997 89: 1987\u20131995","journal-title":"Blood"},{"key":"BF3300999_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1089\/hum.1997.8.15-1815","volume":"8","author":"B Fehse","year":"1997","unstructured":"Fehse B et al. Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (\u0394LNGFR) gene Hum Gene Ther 1997 8: 1815\u20131824","journal-title":"Hum Gene Ther"},{"key":"BF3300999_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.gt.3300666","volume":"5","author":"B Fehse","year":"1998","unstructured":"Fehse B et al. Impact of a new generation of gene transfer markers on gene therapy (editorial) Gene Therapy 1998 5: 429\u2013430","journal-title":"Gene Therapy"},{"key":"BF3300999_CR14","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/jvi.65.5.2220-2224.1991","volume":"65","author":"AD Miller","year":"1991","unstructured":"Miller AD et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus J Virol 1991 65: 2220\u20132224","journal-title":"J Virol"},{"key":"BF3300999_CR15","first-page":"723","volume":"2","author":"SP Forestell","year":"1995","unstructured":"Forestell SP, B\u00f6hnlein E, Rigg RJ . Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production Gene Therapy 1995 2: 723\u2013730","journal-title":"Gene Therapy"},{"key":"BF3300999_CR16","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1128\/MCB.10.8.4239","volume":"10","author":"DG Miller","year":"1990","unstructured":"Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection Mol Cell Biol 1990 10: 4239\u20134242","journal-title":"Mol Cell Biol"},{"key":"BF3300999_CR17","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nm0896-876","volume":"2","author":"H Hanenberg","year":"1996","unstructured":"Hanenberg H et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells Nature Med 1996 2: 876\u2013882","journal-title":"Nature Med"},{"key":"BF3300999_CR18","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1073\/pnas.91.15.7071","volume":"91","author":"MP Kavanaugh","year":"1994","unstructured":"Kavanaugh MP et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters Proc Natl Acad Sci USA 1994 91: 7071\u20137075","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300999_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/hum.1998.9.1-33","volume":"9","author":"M Hildinger","year":"1998","unstructured":"Hildinger M et al. Dominant selection of hematopoietic progenitor cells with retroviral MDR1-coexpression vectors Hum Gene Ther 1998 9: 33\u201342","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3300999.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3300999","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3300999.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:10:23Z","timestamp":1648573823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3300999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10,1]]}},"alternative-id":["BF3300999"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3300999","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10,1]]},"assertion":[{"value":"8 March 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}